Camlin Fine Sciences Limited
Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals
Key metrics
Price as of 2026-07-17
Stock price
₹122.69
Market cap
2,357 Cr
Stock P/E
26.7
P/B
2.35
Dividend yield
0.0%
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 420 Cr | 825 Cr | 1,211 Cr | 1,613 Cr | 396 Cr | 819 Cr | 433 Cr | 437 Cr | 424 Cr | 460 Cr | 457 Cr | 425 Cr |
| Operating expenses (approx.) | 375 Cr | 754 Cr | 1,114 Cr | 1,573 Cr | 376 Cr | 895 Cr | 383 Cr | 374 Cr | 396 Cr | 422 Cr | 450 Cr | 388 Cr |
| EBITDA | 45 Cr | 72 Cr | 97 Cr | 40 Cr | 20 Cr | -76 Cr | 50 Cr | 63 Cr | 28 Cr | 38 Cr | 7 Cr | 37 Cr |
| OPM % | 10.7% | 8.7% | 8.0% | 2.5% | 5.1% | -9.2% | 11.6% | 14.5% | 6.5% | 8.3% | 1.6% | 8.7% |
| Other income | 6 Cr | 8 Cr | 10 Cr | 16 Cr | 2 Cr | 4 Cr | 1 Cr | 10 Cr | 9 Cr | 5 Cr | 3 Cr | 24 Cr |
| Interest | 10 Cr | 30 Cr | 44 Cr | 60 Cr | 23 Cr | 50 Cr | 34 Cr | 16 Cr | 16 Cr | 19 Cr | 18 Cr | 23 Cr |
| Depreciation | 19 Cr | 38 Cr | 59 Cr | 79 Cr | 20 Cr | 41 Cr | 14 Cr | 18 Cr | 17 Cr | 19 Cr | 17 Cr | 21 Cr |
| Profit before tax | 16 Cr | 4 Cr | -6 Cr | -99 Cr | -23 Cr | -166 Cr | 2 Cr | 29 Cr | -5 Cr | 0.27 Cr | -28 Cr | -7 Cr |
| Tax % | 25.3% | 320.7% | -302.4% | -5.7% | -47.6% | 9.0% | 469.5% | 27.5% | 0.2% | 2228.5% | -0.2% | 93.8% |
| Net profit | 12 Cr | -9 Cr | -23 Cr | -105 Cr | -35 Cr | -151 Cr | -7 Cr | 0.11 Cr | -11 Cr | -15 Cr | -37 Cr | 86 Cr |
| EPS (₹) | ₹0.96 | ₹-0.23 | ₹-0.94 | ₹-5.58 | ₹-2.03 | ₹-8.01 | ₹-0.24 | ₹-0.04 | ₹-0.53 | ₹-0.76 | ₹-1.91 | ₹4.59 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2019 | Mar 2020Standalone only | Mar 2021Standalone only | Mar 2022Standalone only | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 892 Cr | 1,049 Cr | 1,187 Cr | 1,412 Cr | 1,682 Cr | 1,613 Cr | 1,667 Cr | 1,723 Cr | Sign in for TTM |
| Operating expenses (approx.) | 824 Cr | 915 Cr | 1,000 Cr | 1,226 Cr | 1,486 Cr | 1,589 Cr | 1,454 Cr | 1,613 Cr | Sign in for TTM |
| EBITDA | 69 Cr | 134 Cr | 187 Cr | 186 Cr | 196 Cr | 24 Cr | 213 Cr | 110 Cr | Sign in for TTM |
| OPM % | 7.7% | 12.8% | 15.7% | 13.2% | 11.6% | 1.5% | 12.8% | 6.4% | Sign in for TTM |
| Other income | 14 Cr | 3 Cr | 5 Cr | 33 Cr | 6 Cr | 16 Cr | 14 Cr | 29 Cr | Sign in for TTM |
| Interest | 37 Cr | 43 Cr | 38 Cr | 36 Cr | 59 Cr | 60 Cr | 100 Cr | 73 Cr | Sign in for TTM |
| Depreciation | 29 Cr | 33 Cr | 44 Cr | 56 Cr | 63 Cr | 79 Cr | 64 Cr | 71 Cr | Sign in for TTM |
| Profit before tax | 17 Cr | 58 Cr | 105 Cr | 94 Cr | 80 Cr | -99 Cr | 49 Cr | -34 Cr | Sign in for TTM |
| Tax % | 81.7% | 48.7% | 37.8% | 35.7% | 50.5% | -5.7% | 0.1% | 1.4% | Sign in for TTM |
| Net profit | 3 Cr | 30 Cr | 65 Cr | 60 Cr | 40 Cr | -105 Cr | -158 Cr | 24 Cr | Sign in for TTM |
| EPS (₹) | ₹0.05 | ₹2.50 | ₹4.13 | ₹4.65 | ₹3.45 | ₹-5.58 | ₹-8.03 | ₹1.46 | Sign in for TTM |
| Dividend payout % | — | — | — | 0.0% | 0.0% | — | — | 0.0% | Sign in for TTM |
Sign in for TTM
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2019 | Mar 2020Standalone only | Mar 2021Standalone only | Mar 2022Standalone only | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 12 Cr | 12 Cr | 13 Cr | 16 Cr | 16 Cr | 17 Cr | 19 Cr | 19 Cr |
| Reserves | 418 Cr | 0.0000 Cr | 631 Cr | 732 Cr | 804 Cr | 848 Cr | 883 Cr | 1,022 Cr |
| Borrowings | 432 Cr | 331 Cr | 363 Cr | 448 Cr | 780 Cr | 658 Cr | 377 Cr | 365 Cr |
| Other liabilities | 225 Cr | 183 Cr | 239 Cr | 306 Cr | 456 Cr | 437 Cr | 772 Cr | 958 Cr |
| Total liabilities | 1,087 Cr | 891 Cr | 1,067 Cr | 1,346 Cr | 2,060 Cr | 1,952 Cr | 2,024 Cr | 2,324 Cr |
| Fixed assets (net) | 209 Cr | 69 Cr | 246 Cr | 251 Cr | 794 Cr | 757 Cr | 593 Cr | 625 Cr |
| CWIP | 54 Cr | 174 Cr | 18 Cr | 207 Cr | 41 Cr | 46 Cr | 10 Cr | 33 Cr |
| Investments | 10 Cr | 74 Cr | 74 Cr | 82 Cr | 8 Cr | 8 Cr | 61 Cr | 30 Cr |
| Other assets | 676 Cr | 541 Cr | 662 Cr | 749 Cr | 1,096 Cr | 1,009 Cr | 1,193 Cr | 1,234 Cr |
| Total assets | 1,087 Cr | 891 Cr | 1,067 Cr | 1,346 Cr | 2,060 Cr | 1,952 Cr | 2,024 Cr | 2,324 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2019 | Mar 2020Standalone only | Mar 2021Standalone only | Mar 2022Standalone only | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | — | — | — | 145 Cr | 51 Cr | 139 Cr | 27 Cr | 82 Cr |
| Cash from investing | — | — | — | -249 Cr | -125 Cr | -66 Cr | -75 Cr | -53 Cr |
| Cash from financing | — | — | — | 136 Cr | 60 Cr | -86 Cr | 72 Cr | -25 Cr |
| Net cash flow | — | — | — | 32 Cr | -14 Cr | -13 Cr | 24 Cr | 4 Cr |
| Free cash flow (OCF − Capex) | — | — | — | -68 Cr | -93 Cr | 78 Cr | -16 Cr | 25 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2019 | Mar 2020Standalone only | Mar 2021Standalone only | Mar 2022Standalone only | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| ROCE % | 4.6% | 835.7% | 22.2% | 17.4% | 8.3% | -3.6% | 11.9% | 2.9% |
| ROE % | 0.1% | 0.0% | 7.9% | 8.1% | 6.3% | -10.8% | -15.9% | 2.8% |
| Debtor days | 85 | 204 | 223 | 234 | 66 | 65 | — | — |
| Inventory days | 221 | 94 | 124 | 136 | 242 | 251 | 244 | 223 |
| Days payable | 132 | 129 | 183 | 202 | 123 | 159 | — | — |
| Cash conversion cycle | 174 | 169 | 165 | 168 | 185 | 156 | 244 | 223 |
| Debt / equity | 1.16 | 0.00 | 0.00 | 0.00 | 0.95 | 0.77 | 0.43 | 0.37 |
| Current ratio | 1.44 | 1.31 | 1.48 | 1.53 | 1.37 | 1.36 | 1.40 | 1.27 |
| Net debt / EBITDA | 5.51 | 0.00 | 0.00 | 0.00 | 3.51 | 23.95 | 1.28 | 2.33 |
Compare with peers
Loading peers…